Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Channel 5 programme: Surgeons: A Matter of Life or Death: Liver Transplantation – broadcast 27th July
In February, this year, our News page included a feature on Liver Transplantation for selected patients diagnosed with Neuroendocrine Cancer and other malignancies (news item here). A topic discussed in one of our podcasts: Episode 19, where NCUK CEO Cathy travelled...
Ancora – Humanising clinical trials with AI
We are thrilled to announce a development that brings renewed hope to the Neuroendocrine Cancer community. Ancora.ai, an innovative company at the forefront of medical technology, is transforming the landscape of clinical trial accessibility for patients with...
Channel 5 programme: Surgeons: A Matter of Life or Death: Carcinoid Heart Disease
We recently featured a paper, on our News page, reviewing the role of serotonin inhibition within the treatment of carcinoid syndrome (CS) - news item here. CS is the most frequent hormonal complication associated with some neuroendocrine cancers. It was first...